Optiver Holding
IRWD icon

Optiver Holding’s Ironwood Pharmaceuticals IRWD Stock Holding History

Optiver Holding’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93K Buy
1,646
+132
+9% +$509 ﹤0.01% 1858
2026
Q1 		$5.31K Buy
1,514
+576
+61% +$2.36K ﹤0.01% 1394
2025
Q4 		$3.16K Sell
938
-1,224
-57% -$3.18K ﹤0.01% 1721
2025
Q3 		$2.83K Buy
2,162
+1,998
+1,218% +$2.07K ﹤0.01% 2221
2025
Q2 		$118 Hold
164
– – ﹤0.01% 1422
2025
Q1 		$241 Hold
164
– – ﹤0.01% 1314
2024
Q4 		$727 Buy
+164
New +$665 ﹤0.01% 1000
2024
Q3 		– Sell
-452
Closed -$2.95K – 1018
2024
Q2 		$2.95K Buy
+452
New +$3.2K ﹤0.01% 827

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Optiver Holding's IRWD Position: Q2 2026 in Review

Optiver Holding increased its Ironwood Pharmaceuticals (IRWD) stake by 8.7% in Q2 2026, buying an estimated $509 and bringing the position to 1,646 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.

Optiver Holding first reported a position in IRWD in Q2 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Optiver Holding held 1,646 shares of Ironwood Pharmaceuticals worth $6.93K as of Q2 2026.
  • Optiver Holding bought 132 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $509.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1858 holding.
  • Optiver Holding first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.